Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryu Watanabe

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Plos One|May 16, 2017
Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in JapanTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Medicine|April 29, 2016
Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Annals of the Rheumatic Diseases|April 28, 2026
Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factorsYuji Nozaki, Toshihiko Shiga, Jinhai Ri, et al.
Modern Rheumatology|May 30, 2024
Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritisYoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2018
Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritisChikashi Terao, Hajime Yoshifuji, Takayoshi Matsumura, et al.
Modern Rheumatology|March 3, 2016
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study GroupYasuhiko Hirabayashi, Yasuhiko Munakata, Masayuki Miyata, et al.
Fukushima Journal of Medical Science|March 29, 2023
Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort studyMasayuki Miyata, Yasuhiko Hirabayashi, Yasuhiko Munakata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2026
JCS 2026 Guideline on Management of Large Vessel VasculitisYoshikazu Nakaoka, Yoshiko Watanabe, Takahiko Sugihara, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Plos One|May 16, 2017
Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in JapanTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Medicine|April 29, 2016
Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyTomohiro Koga, Akitomo Okada, Takaaki Fukuda, et al.
Annals of the Rheumatic Diseases|April 28, 2026
Reduced versus standard dosing of Janus kinase inhibitors in rheumatoid arthritis: a propensity score-matched real-world study accounting for poor prognostic factorsYuji Nozaki, Toshihiko Shiga, Jinhai Ri, et al.
Modern Rheumatology|May 30, 2024
Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritisYoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2018
Genetic determinants and an epistasis of <i>LILRA3</i> and HLA-B*52 in Takayasu arteritisChikashi Terao, Hajime Yoshifuji, Takayoshi Matsumura, et al.
Modern Rheumatology|March 3, 2016
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study GroupYasuhiko Hirabayashi, Yasuhiko Munakata, Masayuki Miyata, et al.
Fukushima Journal of Medical Science|March 29, 2023
Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort studyMasayuki Miyata, Yasuhiko Hirabayashi, Yasuhiko Munakata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2026
JCS 2026 Guideline on Management of Large Vessel VasculitisYoshikazu Nakaoka, Yoshiko Watanabe, Takahiko Sugihara, et al.
Pageof 16